Trial intelligence / Profile preview

APOSTEL II

NL-OMON30860Phase 3Not yet recruiting

Sponsor
Amsterdam University Medical Center
Start
May 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in Preterm labor (PTL) comparing Nifedipine maintenance therapy with Placebo (2 arms). Primary endpoint: Composite neonatal morbidity. Planned start May 2008; status: not yet recruiting.

02

Drugs

nifedipine
03

Conditions

Preterm labor (PTL)

Beyond the preview

Go deeper on NL-OMON30860.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON30860.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call